Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities
Arlhee Diaz-Miqueli,1,* Giselle Saurez Martinez2,* 1Department of System Biology, Center of Molecular Immunology, Havana, Cuba; 2Medical Division, Center of Molecular Immunology, Havana, Cuba *Both authors contributed equally to this manuscript Abstract: Nimotuzumab is a humanized monoclonal antibod...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-07-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/nimotuzumab-as-a-radiosensitizing-agent-in-the-treatment-of-high-grade-a13776 |